VeloClub is CyclingTips’ membership program which brings us closer to our members, and connects likeminded cycling enthusiasts.
by Mark Zalewski
April 13, 2017
In today’s CyclingTips Daily News Digest: Colbrelli wins De Brabantse Pijl; Cavendish diagnosed with mononucleosis from Epstein Barr; Two riders on Czech Continental team test positive, possible team sanction; British Cycling independent review report release delayed again; Wout van Aert to race all the Spring Classics?; In memory of Mike Hall, the man who inspired a world of cyclists; Dibben ‘finished’ Paris-Roubaix despite time cut; No more hippies and explorers: a lament for the changed world of cycling; Could financial problems in Bahrain affect team?; Pon Holdings looking to acquire Accell Group; E-bike legislation signed into law in Colorado; Video: Night Riders by Racing Club; Track Cycling: What is the Omnium?
In addition to recovering from an ankle injury, doctors diagnosed Dimension Data’s Mark Cavendish with mononucleosis caused by the Epstein Barr Virus, resulting in the need for a longer period of rest than originally anticipated.
“Mark has been experiencing some unexplained fatigue during training,” said team doctor Jarrad Van Zuydam.
“Recent blood analysis has revealed him to have infectious mononucleosis caused by the Epstein Barr Virus. Unfortunately, there is no effective specific treatment against the virus but rest will be required to aid his recovery. His training load and symptoms will be monitored very carefully and he will make a gradual, step-wise return to full training and racing.
“It is difficult to give an accurate estimate of when we can expect him back at full fitness but we are hopeful of a significant improvement of his symptoms over the next 2 weeks.
“The main goal for Cavendish remains the Tour de France this year,” a statement said. “Our team is in full support of the Manxman and his ability to bounce back from this unfortunate set back.”